David Cuthbertson

7.9k total citations
114 papers, 3.5k citations indexed

About

David Cuthbertson is a scholar working on Genetics, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Cuthbertson has authored 114 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Genetics, 48 papers in Surgery and 42 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Cuthbertson's work include Diabetes and associated disorders (43 papers), Diabetes Management and Research (39 papers) and Pancreatic function and diabetes (35 papers). David Cuthbertson is often cited by papers focused on Diabetes and associated disorders (43 papers), Diabetes Management and Research (39 papers) and Pancreatic function and diabetes (35 papers). David Cuthbertson collaborates with scholars based in United States, Canada and Finland. David Cuthbertson's co-authors include Jeffrey P. Krischer, Peter A. Merkel, Paul A. Monach, Philip Seo, Carol A. Langford, Gary S. Hoffman, Steven R. Ytterberg, Allen M. Goorin, Michael L. Epstein and Steven E. Lipshultz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David Cuthbertson

112 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Cuthbertson United States	35	1.4k	1.2k	1.1k	910	746	114	3.5k
Neveen A. T. Hamdy Netherlands	41	596 0.4×	873 0.7×	700 0.6×	731 0.8×	661 0.9×	139	4.7k
Reinhard Klingel Germany	27	332 0.2×	975 0.8×	285 0.3×	269 0.3×	266 0.4×	99	3.3k
Martine Aiach France	45	390 0.3×	1.2k 1.0×	502 0.4×	541 0.6×	188 0.3×	212	6.3k
Jean‐Noël Fiessinger France	32	684 0.5×	960 0.8×	426 0.4×	142 0.2×	260 0.3×	80	3.0k
Andrea Hayes‐Jordan United States	33	2.0k 1.5×	1.5k 1.3×	329 0.3×	146 0.2×	606 0.8×	123	3.8k
C. Staudacher Italy	40	1.2k 0.9×	2.4k 2.0×	509 0.4×	388 0.4×	139 0.2×	159	4.2k
Erik A. Imel United States	33	814 0.6×	304 0.3×	1.3k 1.1×	337 0.4×	884 1.2×	100	4.2k
Piero Berti Italy	44	571 0.4×	3.1k 2.6×	713 0.6×	3.2k 3.6×	108 0.1×	126	6.1k
David Buob France	27	405 0.3×	867 0.7×	148 0.1×	600 0.7×	236 0.3×	129	3.3k
Nicola Avenia Italy	43	803 0.6×	3.7k 3.1×	376 0.3×	2.7k 3.0×	103 0.1×	223	6.1k

Countries citing papers authored by David Cuthbertson

Since Specialization

Citations

This map shows the geographic impact of David Cuthbertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cuthbertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cuthbertson more than expected).

Fields of papers citing papers by David Cuthbertson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cuthbertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cuthbertson. The network helps show where David Cuthbertson may publish in the future.

Co-authorship network of co-authors of David Cuthbertson

This figure shows the co-authorship network connecting the top 25 collaborators of David Cuthbertson. A scholar is included among the top collaborators of David Cuthbertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cuthbertson. David Cuthbertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sims, Emily K., David Cuthbertson, Lauric Ferrat, et al.. (2025). IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. Diabetologia. 68(5). 993–1004. 2 indexed citations

Sims, Emily K., David Cuthbertson, Laura M. Jacobsen, et al.. (2024). Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals. The Journal of Clinical Endocrinology & Metabolism. 109(8). 2116–2123. 4 indexed citations

Galderisi, Alfonso, Emily K. Sims, Carmella Evans‐Molina, et al.. (2024). Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab. Diabetologia. 68(3). 646–661. 2 indexed citations

Sosenko, Jay M., David Cuthbertson, Emily K. Sims, et al.. (2023). Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies. Diabetes Care. 46(5). 1098–1105. 9 indexed citations

Beukelman, Timothy, Millie D. Long, Rennie L. Rhee, et al.. (2023). Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research Networks. Patient Related Outcome Measures. Volume 14. 171–180. 1 indexed citations

Springer, Jason, Tanaz A. Kermani, Antoine G. Sreih, et al.. (2022). Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative Analysis. SHILAP Revista de lepidopterología. 11(1). e27273–e27273. 4 indexed citations

Cuthbertson, David, Simon Carette, Nader Khalidi, et al.. (2022). Vitamin D status in ANCA-associated vasculitis. Rheumatology Advances in Practice. 7(1). rkad021–rkad021. 2 indexed citations

Kordonouri, Olga, David Cuthbertson, Neil H. White, et al.. (2022). Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort. Diabetologia. 65(12). 2098–2107. 7 indexed citations

Virtanen, Suvi Μ., David Cuthbertson, Marisa Couluris, et al.. (2021). Effect of extensively hydrolyzed casein vs. conventional formula on the risk of asthma and allergies: The TRIGR randomized clinical trial. Pediatric Allergy and Immunology. 32(4). 670–678. 5 indexed citations

10.

Sims, Emily K., David Cuthbertson, Kevan C. Herold, & Jay M. Sosenko. (2021). The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes. Diabetes. 70(12). 2922–2931. 14 indexed citations

11.

Redondo, María J., Megan Warnock, Ingrid Libman, et al.. (2021). TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes Care. 44(9). 2039–2044. 1 indexed citations

12.

Krischer, Jeffrey P., David Cuthbertson, Marisa Couluris, Mikael Knip, & Suvi Μ. Virtanen. (2020). Association of diabetes-related autoantibodies with the incidence of asthma, eczema and allergic rhinitis in the TRIGR randomised clinical trial. Diabetologia. 63(9). 1796–1807. 8 indexed citations

13.

Pacaud, Danièle, Anita Nucci, David Cuthbertson, et al.. (2020). Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes. Diabetologia. 64(1). 119–128. 8 indexed citations

14.

Springer, Jason, Paul A. Monach, David Cuthbertson, et al.. (2018). Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis. JCR Journal of Clinical Rheumatology. 24(7). 393–395. 18 indexed citations

15.

Jain, Mahim, David Cuthbertson, Deborah Krakow, et al.. (2015). Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta. Genetics in Medicine. 18(6). 570–576. 31 indexed citations

16.

Sekeres, Mikkael A., Alan F. List, David Cuthbertson, et al.. (2010). Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes. Journal of Clinical Oncology. 28(13). 2253–2258. 86 indexed citations

17.

Sosenko, Jay M., Jeffrey L. Mahon, Lisa Rafkin, et al.. (2010). A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants. Pediatric Diabetes. 12(2). 85–90. 12 indexed citations

18.

Malone, John I., et al.. (2006). Cardio-protective effects of carnitine in streptozotocin-induced diabetic rats. Cardiovascular Diabetology. 5(1). 2–2. 18 indexed citations

19.

Merkel, Peter A., David Cuthbertson, G S Hoffman, et al.. (2004). Comparison of disease activity measures for ANCA-associated vasculitis.. Oxford University Research Archive (ORA) (University of Oxford). 4 indexed citations

20.

Chase, H. Peter, David Cuthbertson, Lawrence M. Dolan, et al.. (2001). First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. The Journal of Pediatrics. 138(2). 244–249. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact